Read + Share
Amedeo Smart
Independent Medical Education
Jin ZC, Zhong BY, Chen JJ, Zhu HD, et al. Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study. Eur Radiol 2023;33:8669-8681.PMID: 37368105
Email
LinkedIn
Facebook
Twitter
Privacy Policy